INSTITUTE FOR SYSTEMS BIOLOGY

A nonprofit research organization located in Seattle

THE MOST IMPORTANT ANSWERS COME FROM QUESTIONS THAT HAVE NOT BEEN ASKED.

Yet.

What is Systems Biology

Systems biology has ushered in the future of research. ISB pioneered this approach, which embraces biological complexity and fearlessly sets about deciphering vast amounts of data in order to gain valuable insights and achieve breakthroughs across scientific disciplines.

Why Get Involved

The only true limits to progress are whether we have a critical mass of the right people engaged in ISB’s science, a critical mass of the right collaborators, and a critical mass of the funding required to scale our work across the range of human health and environmental challenges.

Systems Biology of Disease

Latest News

Dr. Eliza Peterson, a senior research scientist who studies tuberculosis (TB) in the Institute for Systems Biology’s Baliga Lab, has been recognized by the University of Washington’s Tuberculosis Research and Training Center with a TB Junior Investigator Award.

“Another vision for health care is emerging — one that is focused on wellness rather than disease; one that is proactive instead of reactive; one that takes a systems approach to biology and medicine rather than studying one gene, one cell or one protein at a time.” Read this Psychology Today story penned by ISB’s Lee Hood and Nathan Price.

“Excessive spending and poor outcomes in health care and drug development necessitate the search for new research paradigms to translate cutting-edge, scientific discoveries of systems medicine into the clinic more quickly and efficiently.” ISB’s Kalliopi Trachana and colleagues, wrote “Taking Systems Medicine to Heart,” which was published in Circulation Research.

ISB’s 2018 Consilience event on the topic of “Exploring Plasticity” will be held on Friday afternoon, May 25th. Speakers featured: Chris Young, CEO of ChefSteps and Michael Merzenich, PhD, CEO of BrainHQ.

ISB’s computational and bioinformatics teams played a central role in the completion of the PanCancer Atlas Initiative, the final phase of TCGA. The culmination of this work is being published in 27 papers this week across the Cell Press research journals, including “The Immune Landscape of Cancer” in Immunity.

Three organizations on the forefront of cancer immunotherapy, systems biology and bioinformatics announced the release of the Cancer Research Institute iAtlas, a comprehensive web-based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment.